where R1, X, Y and B have the corresponding meanings, or their pharmaceutically acceptable additive acid salts, or heterocyclic compound N-oxide, or additive acid salt. These compounds were used in pharmaceutical compositions at concentration 0.5-730 mg per a dose. Synthesized compounds were used in medicine as antagonists of specific 5-hydroxytryptamine (5-HT) receptors for treatment patients with neuropsychiatric disorders. EFFECT: improved method of synthesis."/>
公开/公告号RU2047614C1
专利类型
公开/公告日1995-11-10
原文格式PDF
申请/专利权人 DZHON VAJS END BRAZER LIMITED;
申请/专利号SU19925011928
申请日1992-06-15
分类号C07D403/12;C07D405/12;C07D215/233;C07D311/58;C07D451/04;C07D451/12;A61K31/335;A61K31/46;A61K31/47;
国家 RU
入库时间 2022-08-22 04:10:16